Collaborative Care in Posttraumatic Epilepsy
Collaborative Care for Anxiety and Depression in Posttraumatic Epilepsy
3 other identifiers
interventional
40
1 country
1
Brief Summary
The purpose of this research is to evaluate a 6 month change in quality of life in subjects who receive collaborative care calls compared to those subjects who receive usual neurology care. This is a 2-site trial comparing a 24 week neurology-based collaborative care program to usual neurology care among a total of 60 adults with post-traumatic epilepsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2022
CompletedFirst Posted
Study publicly available on registry
April 29, 2022
CompletedStudy Start
First participant enrolled
April 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedFebruary 3, 2026
January 1, 2026
3 years
April 25, 2022
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Emotional Subscale-Change in Quality of Life in Epilepsy-31(QOLIE-31)
This is a clinically meaningful patient reported outcome measure that was demonstrated to improve in collaborative care efficacy trials in distinct patient groups (including with various different types of medical illness) Score ranges from 0-100 with higher score indicating better quality of life
Baseline through Month 6
Secondary Outcomes (4)
Subject Adherence to Intervention
Week 12
Change in Epilepsy specific QOLIE-31 score
Baseline through Month 6
Change in Beck Depression Inventory-II (BDI-II) score
From baseline through Month 6
Change in Beck Anxiety Index (BAI) score
From baseline through Month 6
Other Outcomes (22)
Feasibility of Intervention Measure (FIM)-Subject Perspective
Baseline and Month 3
FIM-Neurologist Perspective
Baseline and Month 3
Acceptability of Intervention Measure (AIM)-Subject Perspective
Baseline and Month 3
- +19 more other outcomes
Study Arms (2)
Collaborative Care
EXPERIMENTALParticipants in this arm will receive 24 weeks of neurology based collaborative care.
Standard of Care (SOC)
ACTIVE COMPARATORParticipants in this arm will receive provider-recommended clinic visits, prescriptions, testing, and referrals.
Interventions
Usual neurology care means ongoing, epilepsy provider-recommended clinic visits, prescriptions, testing and referrals from their epilepsy provider. Mental health referrals or prescribing of antidepressants may potentially occur in this group; these types of interventions will be tracked at outcome assessments.
Twenty-four week, evidence-based remote collaborative care model initiated around the time of a neurology visit. The collaborative care team roles include the care manager, psychiatrist, and psychologist/social worker who interact with the patient participant and the patient's neurologist.
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures
- Diagnosis of post-traumatic epilepsy, defined by the following:
- Epilepsy diagnosis based on neurology clinician impression of diagnosis or electroencephalogram (EEG) findings (EEG findings: presence of interictal epileptiform discharges on EEG or ictal EEG recording of seizure definitively documenting epilepsy diagnosis)
- History of at least mild traumatic brain injury based on the MIRECC (Mental Illness Research, Education, and Clinical Center) TBI (Traumatic Brain Injury) screening instrument or verified TBI history based on MIRECC research database
- TBI pre-dated onset of epilepsy (NINDS post-traumatic epilepsy screening form)
- Anxiety or depression symptoms--Generalized Anxiety Disorder scale (GAD-7) ≥8 or Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) \>13
- Receiving clinical neurological care at one of the study sites
You may not qualify if:
- Active ongoing treatment by a psychiatrist without the potential to benefit from additional collaborative care for anxiety or depression in the judgement of the investigators
- Active suicidal ideation
- History of past suicide attempt
- Unstable drug or alcohol abuse
- Unstable or progressive comorbid medical condition
- Current participation in another treatment or intervention study
- Cognitive limitations precluding completion of anxiety and depression self-report instruments on paper, electronically, or by interview.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
Related Publications (1)
Munger Clary HM, Snively BM, Cagle C, Kennerly R, Kimball JN, Alexander HB, Brenes GA, Moore JB, Hurley RA. Collaborative Care to Improve Quality of Life for Anxiety and Depression in Posttraumatic Epilepsy (CoCarePTE): Protocol for a Randomized Hybrid Effectiveness-Implementation Trial. JMIR Res Protoc. 2024 Nov 13;13:e59329. doi: 10.2196/59329.
PMID: 39535875DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heidi M. Munger Clary, MD, MPH
Atrium Health Wake Forest Baptist
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2022
First Posted
April 29, 2022
Study Start
April 30, 2023
Primary Completion
May 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
February 3, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share